Nutrient system for individualized responsive dosing regimens
Abstract
Individualized responsive dosing dietary supplement systems, compositions, methods of dosing, and processes of producing the same, which allow a consumer to generate individualistic biological responses/effects. More specifically, a dietary supplement system for generating individualized biological conditions/responses which utilizes ultra-low dosage amounts of vitamins, minerals, amino acids, co-enzymes, and/or other nutrients in a bio-active delivery system which preferably avoids first pass metabolism, such that an individual may take multiple doses of the same or different dietary supplement based on varying desired biological response within each 24 period is also disclosed.
Claims
exact text as granted — not AI-modified1 . A process for producing a nutrient system for individualized responsive dosing comprising the steps of:
(a) providing an amount of water; (b) adding a base composition, wherein
i. the base composition comprises at least two vitamins or minerals;
ii. the base composition is selected from a group of two or more base-compositions configured to generate one or more pre-determined biological effects; and
iii. optionally at least one amino acid or co-enzyme;
(c) adding a pre-mix composition comprising a blend of
i. at least one vitamin; and
ii. at least one mineral;
(d) optionally diluting an intermediate mixture of water, base composition, and pre-mix composition by a dilution factor; (e) configuring the mixture comprising the water, base composition, and pre-mix composition into a final formulation which substantially avoids first-pass metabolism, wherein the final formulation comprises between about 1×10{circumflex over ( )}-7% of the RDA, DV, or UL to about 10% of the RDA, DV, or UL of any vitamin, mineral, amino acid, or co-enzyme; and (f) repeating steps (a)-(e) one or more times by utilizing
i. a different base composition; or
ii. a different dilution factor.
2 . The process of claim 1 , wherein the base composition contains the pre-mix.
3 . The process of claim 1 , wherein the pre-mix composition components have constant weight percentages in relation to one another.
4 . The process of claim 1 , further comprising the step of multiplying the amount of base mixture by a multiplication factor before adding it to the mixture.
5 . The process of claim 1 , wherein the final formulation is delivered via an oral film, a tablet, a pill, a liquid, a capsule, a lozenge, a suppository, a nasal spray, or a troche capable of avoiding first-pass metabolism.
6 . The process of claim 5 , wherein the final formulation is delivered via an oral film.
7 . The process of claim 1 , wherein the pre-determined biological effect for each of the two or more pre-configured base mixtures is selected from the group consisting of:
stress-relief, cellular metabolism, energy conservation, energy utilization, enhanced memory, enhanced cognitive function, calmness, stimulation of the hypothalamic-pituitary-thyroid axis, fatigue relief, awareness, enhanced immune response, antioxidation, liver detoxification, and alcohol metabolism.
8 . The process of claim 1 , wherein the base mixture and pre-mix composition in combination comprise an amount of between about 0.01% to about 0.30% by weight of the mixture comprising base mixture, pre-mix composition, and water.
9 . The process of claim 6 , wherein the water is selected from a Shenandoah Valley water source.
10 . The process of claim 1 , wherein the amount of any vitamin or mineral in the final formulation is between about 1×10′-7% of the RDA, DV, or UL to about 1% of the RDA or UL.
11 . The process of claim 1 , wherein the amount of any vitamin or mineral in the final formulation is between about 1×10{circumflex over ( )}-7% of the RDA, DV, or UL to about 0.001% of the RDA or UL.
12 . The process of claim 1 , wherein the base-mixture comprises at least two of the members of the group consisting of: magnesium chloride, sodium chloride, potassium chloride, calcium chloride, ascorbic acid, caffeine, niacin, potassium benzoate, chromium picolinate, chromium, polynicolinate, coenzyme Q10, L-glutamine, potassium sorbate, calcium ascorbate, sodium nitrite, L-arginine, sodium ascorbate, and combinations and derivatives thereof.
13 . The process of claim 12 , wherein the base-mixture comprises at least five of the members of the group consisting of: magnesium chloride, sodium chloride, potassium chloride, calcium chloride, ascorbic acid, caffeine, niacin, potassium benzoate, chromium picolinate, chromium, polynicolinate, coenzyme Q10, L-Glutamine, potassium sorbate, calcium ascorbate, sodium nitrite, L-arginine, sodium ascorbate, and combinations and derivatives thereof.
14 . The process of claim 3 , wherein each of the two or more pre-configured base-mixtures comprises the components and relative amounts of a member from the group consisting of Series S, Series T, Series U, Series V, Series K, Series L, Series M, Series N, Series X, and Series W.
15 . The process of claim 1 , wherein the pre-mix composition comprises two or more of the members of the group consisting of: vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin C, vitamin D3, vitamin E, vitamin H, folic acid, copper, iron, potassium iodide, calcium carbonate, zinc, and combinations and derivatives thereof.
16 . The process of claim 15 , wherein the pre-mix composition comprises five or more of the members of the group consisting of: vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin C, vitamin D3, vitamin E, vitamin H, folic acid, copper, iron, potassium iodide, calcium carbonate, zinc, and derivatives thereof.
17 . The process of claim 1 , wherein the base composition further comprises a stimulant in an amount such that the concentration of stimulant is less than about 50 milligrams per dose of final formulation.
18 . The process of claim 17 , wherein the stimulant is caffeine present in the final formulation in an amount less than about 5 milligrams per dose.
19 . A base mixture for producing an individualized responsive dosing dietary supplement composition or system wherein,
(a) the base mixture is configured to generate one or more pre-determined biological effects; (b) the base mixture comprises two or more vitamins or minerals; (c) the base mixture is configured to provide no more than about 10% of the RDA, DV, or UL of any vitamin or mineral in a finished dietary supplement formulation.
20 . The base mixture of claim 19 , wherein the base mixture is configured to provide no more than about 0.01% of the RDA, DV, or UL for any vitamin or mineral in one dose of an individualized responsive dosing dietary supplement composition or system.
21 . The base mixture of claim 19 , comprising at least five of the members of the group consisting of: magnesium chloride, sodium chloride, potassium chloride, calcium chloride, ascorbic acid, caffeine, niacin, potassium benzoate, chromium picolinate, chromium, polynicolinate, coenzyme, L-glutamine, potassium sorbate, calcium ascorbate, sodium nitrite, L-arginine, sodium ascorbate, and combinations and derivatives thereof.
22 . The base mixture of claim 21 , wherein the base mixture comprises the components and relative amounts of a member from the group consisting of Series S, Series T, Series U, Series V, Series K, Series L, Series M, Series N, Series X, and Series W.
23 . A pre-mix composition for use in an individualized responsive dosing dietary supplement composition, wherein
(a) the pre-mix composition comprises two or more compounds selected from the group consisting of: vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin C, vitamin D3, vitamin E, vitamin H, folic acid, copper, iron, potassium iodide, calcium carbonate, zinc, amino acids, co-enzyme Q-10, and derivatives thereof; and (b) the pre-mix composition is configured to provide no more than 10% of the RDA, DV, or UL of any vitamin, mineral, amino acid, or co-enzyme in each dose of a finished individualized responsive dosing dietary supplement formulation.
24 . The pre-mix composition of claim 23 , wherein the pre-mix composition is a component of an individualized responsive dosing system, method, or series of compositions which allows for individualized enhancement of biological functions.
25 . The pre-mix composition of claim 23 , configured to provide no more than 0.01% of the RDA, DV, or UL of any vitamin, mineral, amino acid, or co-enzyme in each dose of a finished individualized responsive dosing dietary supplement formulation.
26 . The pre-mix composition of claim 23 , comprising five or more compounds selected from the group consisting of vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin C, vitamin D3, vitamin E, vitamin H, folic acid, copper, iron, potassium iodide, calcium carbonate, zinc, amino acids, co-enzyme, combinations and derivatives thereof.
27 . An individualized responsive dosing treatment method comprising selecting from two or more dietary supplement formulations in delivery systems which substantially avoid first pass metabolism, wherein each member of a selection of dietary supplement formulations comprises:
(a) five or more vitamins, minerals, amino acids, or co-enzyme Q-10 in amounts no greater than about 10% of the RDA, DV, or UL; (b) water containing at least one mineral, nitrate, and nitrite, each in an amount less than about 10% of the RDA, DV, or UL; and (c) optionally, a stimulant; wherein, any selected dietary supplement formulations is separately configured to generate a pre-determined biological response and wherein, the dietary supplement formulation may be taken by an individual two or more times within each day.
28 . The method of claim 27 , wherein two or more different selections from the group of two or more dietary supplement formulations may be taken by an individual each 24 hour period.
29 . The method of claim 27 , wherein the pre-determined biological response is selected from the group consisting of: stress-relief, cellular metabolism, energy conservation, energy utilization, enhanced memory, enhanced cognitive function, calmness, awareness, stimulation of the hypothalamic-pituitary-thyroid axis, fatigue relief, enhanced immune response, antioxidation, liver detoxification, and alcohol metabolism.
30 . The method of claim 27 , wherein each delivery for the dietary supplement formulations is an oral film, a tablet, a pill, a liquid, a capsule, a lozenge, a nasal spray, a suppository, or a troche capable of avoiding first-pass metabolism.
31 . The method of claim 27 , wherein the water is selected from a Shenandoah Valley water source.
32 . The method of claim 27 , wherein the dietary supplement formulation comprises between about 1×10{circumflex over ( )}-7% of the RDA, DV, or UL to about 1% of the RDA, DV, or UL of at least five of the members of the group consisting of: magnesium chloride, sodium chloride, potassium chloride, calcium chloride, ascorbic acid, caffeine, niacin, potassium benzo ate, chromium picolinate, chromium, polynicolinate, coenzyme, L-Glutamine, potassium sorbate, calcium ascorbate, sodium nitrite, L-Arginine, sodium ascorbate, and combinations and derivatives thereof.
33 . The method of claim 27 , wherein the dietary supplement formulation further comprises between about 0.0001% of the RDA, DV, or UL to about 1% of the RDA, DV, or UL of five or more of the members of the group consisting of: vitamin A, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin C, vitamin D3, vitamin E, vitamin H, folic acid, copper, iron, potassium iodide, calcium carbonate, zinc, and combinations and derivatives thereof
34 . The method of claim 27 , wherein the stimulant is caffeine present in the dietary supplement formulation in an amount less than 20 milligrams.
35 . A product produced by the process of claim 1.Join the waitlist — get patent alerts
Track US2005226906A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.